Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nikolaos Pisanidis"'
Autor:
G. Vourli, M. Stavropoulos, D.V. Skarlos, George Fountzilas, Theofanis Economopoulos, Charisios Karanikiotis, Angelos Koutras, Georgios Pentheroudakis, Haralabos P. Kalofonos, D.G. Pectasides, Despina Misailidou, Christos Papadimitriou, Nikolaos Pisanidis, G. Basdanis, Maria Karina, Pavlos Papakostas, Epaminontas Samantas, Dimitrios Kardamakis, Dimitris Bafaloukos, Aristotle Bamias
Publikováno v:
European Journal of Cancer. 44:1693-1700
The primary objective was to compare the 3-year survival of rectal cancer patients randomised postoperatively to irinotecan (IRI), Leucovorin (LV) and bolus 5-fluorouracil (5FU) or LV-bolus 5FU with radiotherapy. Secondary objectives included disease
Autor:
Elke Veltrup, Gerasimos Aravantinos, Flora Zagouri, Haralambos P. Kalofonos, Konstantine T. Kalogeras, George Fountzilas, Mattheos Bobos, Christos Christodoulou, Dimitrios Bafaloukos, Eleni Timotheadou, Nikolaos Pisanidis, Angelos Koutras, Zoi Alexopoulou, Dimitrios Pectasides, Ralph M. Wirtz, Christina Magkou, George Pentheroudakis, Pavlos Papakostas, Helen Gogas
Publikováno v:
Journal of Translational Medicine
Background The aim of the study was to evaluate the prognostic ability of the transcriptional profiling of the HER family genes in early breast cancer, as a validation analysis of another previously published HeCOG study. Methods RNA was extracted fr
Autor:
Meletios-Athanassios Dimopoulos, George Fountzilas, Christos Christodoulou, Pavlos Papakostas, Nikolaos Pisanidis, Christos Papadimitriou, George Pentheroudakis, George Kouvatseas, Dimitrios Bafaloukos, Epaminontas Samantas, Gerasimos Aravantinos, Paris Kosmidis, Vasilios Karavasilis, Dimitrios Pectasides, Charisios Karanikiotis, Angelos Koutras, Helen Gogas
Publikováno v:
Clinical Breast Cancer. 16:291-298.e3
Intensive chemotherapy confers benefit to patients with high-risk early breast cancer (BC). We characterized the feasibility and toxicity profile of anthracycline-containing adjuvant chemotherapy (ACAC) in older women with early BC.Available data fro
Autor:
Ioannis Efstratiou, Nikolaos Xiros, George Fountzilas, Meletios A. Dimopoulos, Georgia Kafiri, Theofanis Economopoulos, Dimitrios Pectasides, Aristotelis Bamias, Pavlos Papakostas, Dimosthenis Miliaras, Epaminontas Samantas, Irene Papaspirou, Dimitrios Bafaloukos, Maria Karina, Christos Papadimitriou, G. Klouvas, Ippokratis Korantzis, Lia Malettou, Gerasimos Aravantinos, F. Matsiakou, George Basdanis, George Pentheroudakis, Charisios Karanikiotis, Thomas Makatsoris, Nikolaos Pisanidis, Haralabos P. Kalofonos
Publikováno v:
BMC Medicine, Vol 9, Iss 1, p 10 (2011)
BMC Medicine
BMC Medicine
Background Colon cancer is a public health problem worldwide. Adjuvant chemotherapy after surgical resection for stage III colon cancer has been shown to improve both progression-free and overall survival, and is currently recommended as standard the
Autor:
A. Polichronis, Helena Linardou, George Fountzilas, Epaminontas Samantas, Papadimitriou Ca, P. Makrantonakis, N. Xiros, Maria Karina, Pavlos Papakostas, Ioannis Varthalitis, K. Dimitrakakis, E. Tzorakoeleftherakis, E. Briasoulis, Urania Dafni, H. P. Kalofonos, Dimitrios Pectasides, Dimitris Bafaloukos, A. M. Dimopoulos, Nikolaos Pisanidis, Charisios Karanikiotis, George P. Stathopoulos, D.V. Skarlos, Christos Markopoulos, Helen Gogas
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 19(5)
BACKGROUND: A randomized phase III trial in high-risk breast cancer patients was conducted, to further explore the impact of dose-density in the adjuvant treatment for breast cancer. The safety analysis is presented. PATIENTS AND METHODS: From Octobe
Autor:
Pavlos Papakostas, Nikolaos Pisanidis, P. Makrantonakis, Helen Gogas, George Pentheroudakis, Gerasimos Aravantinos, Flora Stavridi, Konstantine T. Kalogeras, Kyriaki Pliarchopoulou, Angelos Koutras, Ralph M. Wirtz, Eleni Galani, George Kouvatseas, Flora Zagouri, George Fountzilas, Georgios Lazaridis
Publikováno v:
Journal of Clinical Oncology. 32:1077-1077
1077 Background: Early breast cancer is a heterogeneous disease, and, therefore, prognostic tools have been developed to evaluate the risk for distant recurrence. We compared the Clinical Treatment...
Autor:
Eleni Timotheadou, Angelos Koutras, George Pentheroudakis, Nikolaos Pisanidis, Christos Papadimitriou, Christos Christodoulou, Dimitrios G. Pectasides, Dimitris Bafaloukos, Epaminontas Samantas, Konstantine T. Kalogeras, George Fountzilas, Flora Stavridi, Kyriaki Pliarchopoulou, Meletios A. Dimopoulos, George Kouvatseas, Ralph M. Wirtz, Helen Gogas
Publikováno v:
Journal of Clinical Oncology. 31:582-582
582 Background: Proliferation is a major process in carcinogenesis. RACGAP1 is a protein involved in cell growth regulation and metastasis, Ki67 is a known proliferation marker and TOP2A has a key role in DNA replication and remodeling. The aim of th